CFD and metabolic dysfunction-associated steatotic liver disease: Both CFD and C3AR1 were unchanged in obese subjects without MASLD compared to healthy controls, but both CFD and C3AR1 were significantly downregulated in liver biopsies from both MASLD and MASH patients compared to both healthy controls and obese subjects without MASLD (Figure 1C).